Results 201 to 210 of about 95,044 (332)

Targeted therapy for idiopathic pulmonary fibrosis: a bibliometric analysis of 2004-2024. [PDF]

Front Med (Lausanne)
Zhang X, Yuan Z, Shi X, Yang J.
europepmc   +1 more source

Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry

Respirology, EarlyView.
ABSTRACT Background and Objective Real‐world data on lung function course of patients with progressive pulmonary fibrosis (PPF) treated with anti‐fibrotic medication are limited. We evaluated forced vital capacity (FVC) decline in patients with PPF and idiopathic pulmonary fibrosis (IPF) who started anti‐fibrotic treatment.
Mark G. J. P. Platenburg, Gizal Nakshbandi, Catharina C. Moor, Aernoud A. van Batenburg, Rémy L. M. Mostard, Mareye Voortman, Linda A.A. Moonen, Nicolle Hekelaar, Maria J. Overbeek, Brigitte A.H.A. Bogaarts, Henk Kramer, Emiel. R. Marges, Bart B. Boerrigter, Paul Bresser, Eveline L. Schakenraad, Jan van der Maten, Niels C.A. van der Sloot, Stefan Walen, Pedro Miranda Afonso, Marlies S. Wijsenbeek, Jan C. Grutters   +20 more
wiley   +1 more source

Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis [PDF]

, 2003
Marco Chilosi, Venerino Poletti, Alberto Zamò, Maurizio Lestani, Licia Montagna, P Piccoli, Serena Pedron, Manuela Bertaso, Aldo Scarpa, Bruno Murer, Alessandra Cancellieri, Roberta Maestro, Gianpietro Semenzato, Claudio Doglioni   +13 more
openalex   +1 more source

Impaired Right, Left, or Biventricular Function and Resting Oxygen Saturation Are Associated With Mortality in Eisenmenger Syndrome: A Clinical and Cardiovascular Magnetic Resonance Study. [PDF]

, 2015
Babu-Narayan, SV, Broberg, CS, Diller, GP, Dimopoulos, K, Gatzoulis, MA, Jensen, AS, Li, W, Pennell, DJ, Rydman, R, Wort, SJ   +9 more
core   +1 more source

Enhancing Interstitial Lung Disease Diagnoses Through Multimodal AI Integration of Histopathological and CT Image Data

Respirology, EarlyView.
ABSTRACT Background and Objective The diagnosis of interstitial lung diseases (ILDs) often relies on the integration of various clinical, radiological, and histopathological data. Achieving high diagnostic accuracy in ILDs, particularly for distinguishing usual interstitial pneumonia (UIP), is challenging and requires a multidisciplinary approach ...
Kris Lami, Mutsumi Ozasa, Xiangqian Che, Wataru Uegami, Yoshihiro Kato, Yoshiaki Zaizen, Naoko Tsuyama, Ichiro Mori, Shin Ichihara, Han‐Seung Yoon, Ryoko Egashira, Kensuke Kataoka, Takeshi Johkoh, Yasuhiro Kondo, Richard Attanoos, Alberto Cavazza, Alberto M. Marchevsky, Frank Schneider, Jaroslaw Wojciech Augustyniak, Amna Almutrafi, Alexandre Todorovic Fabro, Luka Brcic, Anja C. Roden, Maxwell Smith, Andre Moreira, Junya Fukuoka   +25 more
wiley   +1 more source

Corticosteroids for idiopathic pulmonary fibrosis [PDF]

, 2003
Luca Richeldi, Huw Richard H R Davies, Paolo Spagnolo, Fabrizio Luppi   +3 more
openalex   +1 more source

Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis. [PDF]

J Clin Med
Mullholand JB, Grossman CE, Perelas A.
europepmc   +1 more source

Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis

Respirology, EarlyView.
ABSTRACT Background and Objective Approximately 30% of individuals diagnosed with familial pulmonary fibrosis (FPF) exhibit a pathogenic variant upon genetic analysis. We established a genetic Multidisciplinary Discussion (geneMDD) aimed to enhance expertise in diagnosing and managing FPF.
Giovanni Franco, Ibrahima Ba, Nadia Nathan, Cécile Guerin, Albane Lassus, Caroline Kannengiesser, Antoine Froidure, Effrosyni Manali, Vincent Bunel, Philippe Bonniaud, Diane Bouvry, Marie Pierre Debray, Pierre Antoine Juge, Ralph Epaud, Camille Louvrier, Aurélie Plessier, Flore Sicre de Fontbrune, Lidwine Wémeau‐Stervinou, Sylvain Marchand Adam, Alexandre Chabrol, Arnaud Maurac, Laurent Savale, David Montani, Caroline Raynal, Marina Konyukh, Arthur Mageau, Bruno Crestani, Vincent Cottin, Alix de Becdelièvre, Raphaël Borie, Respifil and OrphaLung   +30 more
wiley   +1 more source

Epidemiology of idiopathic pulmonary fibrosis in central and Western Pennsylvania. [PDF]

Respir Res
Linkov F, Chang YF, Ramanan H, Morgan RS, McTigue KM, Dimmock AEF, Bascom R, Kass DJ.   +7 more
europepmc   +1 more source

Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis

Respirology, EarlyView.
ABSTRACT Background and Objective Idiopathic pulmonary fibrosis is a progressive interstitial lung disease characterised by excessive activation of myofibroblasts. However, currently available antifibrotic drugs exhibit limited efficacy. The dysregulation of redox processes plays a significant role in the pathogenesis of idiopathic pulmonary fibrosis ...
Jie Huang, Nana Liu, Yueyue Jin, Shuangyu Han, Lian Li, Yunze Du, Luqing Wei, Dongsheng Li, Yan Zhang, Yubao Wang, Jau‐Shyong Hong, Wen Ning, Jing Feng   +12 more
wiley   +1 more source